BioSpace News Archive

Elicio Therapeutics, a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, today announced that it will present preclinical data on its AMP-CpG adjuvant (AMP-CpG) at the Vaccines Summit 2021, being held virtually from September 20-22, 2021.

Renovia Inc. (“Renovia”), a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced that the Digital Therapeutics Alliance (DTA) has added the leva® Pelvic Health System to its Product Library of innovative treatments that meet DTA’s definition of an evidence-based digital therapeutic satisfying its ten rigorous Core Principles.

Detailed results from the positive DESTINY-Gastric02 Phase II trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), the AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) HER2-directed antibody drug conjugate (ADC) provided a clinically meaningful and durable tumor response in patients with HER2-positive metastatic and/or unresectable gastric or gastroesophageal junction (GEJ) adenocarcinoma previously treated with a trastuzumab-containing regimen.

Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, announced it has granted inducement awards to eight newly hired employees under an inducement plan adopted by its board of directors.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.

Auto-injector is a medical device designed to deliver a dose of a particular drug. Disposable and reusable auto-injectors are the two types of auto-injector.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others.

The diaphragm pacing therapy system market is expected to observe a positive growth trajectory during the forecast period of 2020-2030.

Presently, a number of health problems related to stomach such as ulcer, liver, intestinal pain and cancer, and skin related problems are rising rapidly.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to a recent study by Fact.MR, the global adenovirus testing market is forecast to exhibit positive growth between 2021 and 2031.